Global Medical REIT (GMRE)
(Delayed Data from NYSE)
$8.20 USD
+0.01 (0.12%)
Updated Apr 22, 2024 04:00 PM ET
After-Market: $8.20 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value F Growth D Momentum D VGM
Price, Consensus and EPS Surprise
GMRE 8.20 +0.01(0.12%)
Will GMRE be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for GMRE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for GMRE
After Plunging -11.42% in 4 Weeks, Here's Why the Trend Might Reverse for Global Medical REIT (GMRE)
Global Medical REIT (GMRE) Misses Q4 FFO and Revenue Estimates
GMRE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Insights Into Global Medical REIT (GMRE) Q4: Wall Street Projections for Key Metrics
City Office REIT (CIO) Q4 FFO Meet Estimates
Should You Buy Global Medical REIT (GMRE) After Golden Cross?
Other News for GMRE
REITs finish March trading at 15% discount to NAV per share estimates
GMRE Named Top 10 REIT at Dividend Channel With 9.69% Yield
GMRE Breaks Above 10% Yield Territory
Ex-Div Reminder for Global Medical REIT (GMRE)
Global Medical REIT: Dividend Insights